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ABSTRACT
The Nipah virus is highly virulent to swine and humans. The envelope attachment glycoprotein (G) of Nipah virus 
plays a key role in viral entry and induction of neutralizing antibody in mammalian hosts, thus is considered a good 
candidate for vaccine development. Plant transient expression systems are gaining recognition as a viable alternative 
for the production of vaccine antigens. In this study, we expressed the Nipah virus G protein heterologously in Nicotiana 
benthamiana using an agroinfiltration approach. The highest expression of recombinant G protein in N. benthamiana at 
RNA and protein levels was detected on day 9 post-infiltration. Western blot analysis demonstrated that the purified G 
protein reacted specifically with rabbit anti-Nipah Virus serum, indicating its potential for vaccine use. 
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ABSTRAK
Virus Nipah adalah virus yang sangat virulen bagi ternakan khinzir dan manusia. Pelekat sampul sel gliko protein 
G virus Nipah memainkan peranan penting dalam kemasukan virus dan peneutralan antibodi di dalam sel perumah 
mamalia. Oleh itu, ia dianggap sebagai satu calon yang baik untuk dijadikan vaksin. Memandangkan sistem asai transien 
dalam tumbuhan semakin diberi perhatian sebagai cara alternatif penghasilan vaksin, protein G virus Nipah telah 
diekspres dalam tumbuhan Nicotiana benthamiana menerusi kaedah agroinfiltrasi di dalam kajian ini. Dalam kajian 
ini, pengekspresan RNA dan protein G dalam Nicotiana benthamiana mencapai tahap maksimum pada hari ke-9 selepas 
infiltrasi. Protein G yang ditulenkan menunjukkan tindak balas yang khusus dengan serum arnab anti-Nipah virus dalam 
analisis pedapan Western. Penemuan ini menunjukkan protein rekombinan G virus Nipah berpotensi dijadikan vaksin. 
Kata kunci: Bioteknologi; KDEL; tembakau PR1-a; tumbuhan; vaksin
INTRODUCTION
Nipah virus (NiV) belongs to the genus Henipavirus 
and is closely related to the type species, Hendra virus 
(Eaton et al. 2006; Mayo 2002; Wang et al. 2000). NiV is 
a pathologenic paramyxovirus, which has been found to 
be the etiologic agent for both human and swine diseases 
(Chua et al. 2000). It was first isolated in 1999 from pigs 
and adult human males affected by fever and encephalitis, 
some with respiratory illness, during a major outbreak 
in peninsular Malaysia and then Singapore (Chua et al. 
1999; Paton et al. 1999). Most of the people affected in 
the Malaysian outbreak had a history of direct contact 
with live pigs and the majority pig farmers of Chinese 
adult male ethnic with a 40% clinical case mortality rate 
(Parashar et al. 2000). 
 The known natural reservoir hosts of NiV are pteropid 
fruit bats, commonly known as flying foxes, which do 
not exhibit any clinical disease when infected (Halpin 
et al. 2011). NiV can infect and cause disease in a wide 
range of species with very high fatality rates (Geisbert 
et al. 2012; Wong & Ong 2011). Fatal NiV outbreaks 
among people have occurred almost annually since 2001 
(Broder 2012; Luby et al. 2009) most of them in India 
and Bangladesh. Due to poor surveillance in rural areas in 
Bangladesh whereNiV is endemic, the true disease burden 
is uncertain and likely many cases go undetected, however 
the estimated case-fatality rate is 67% (Herriman 2015). 
Unlike the Malaysian outbreak, the transmission method 
of NiV in Bangladesh and India was from bats to humans 
in the absence of an intermediate animal host via food 
contaminated with bat saliva (Clayton et al. 2016; Luby 
et al. 2012). On the other hand, human infection in the 
Bangladesh outbreak is associated with drinking traditional 
liquor made from date palm sap (Islam et al. 2016). 
 The NiV genome encodes two different surface 
glycoproteins, the receptor-binding G protein and the 
fusion (F) protein. The main role of the G protein is to 
recognize and attach the virus to receptors on host cell 
membranes. It also facilitates the F-mediated membrane 
fusion process via a mechanism of receptor-induced 
paramyxovirus F triggering during viral entry and cell-cell 
fusion as proposed by Liu et al. (2015).
 Current prevention of NiV disease in endemic 
countries relies on behavior modifications to prevent 
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spillover, including farming practices which decreased 
livestock exposure to bats, the use of bamboo skirts to 
prevent date palm sap contamination and pasteurizing date 
palm sap. Though these approaches appear to be effective 
strategies of prevention, their implementation is often 
problematic due to cultural factors (Satterfield et al. 2016). 
Effective therapy and vaccine are needed to combat the 
threats posed by NiV. Various candidate vaccine platforms 
have demonstrated the feasibility of using one or both of 
the NiV outer-membrane proteins, the glycoprotein (G) and 
fusion (F) protein, as antigen(s) to stimulate a protective 
immune response in various preclincal animal challenge 
models such as hamsters (Debuysscher et al. 2014; Lo 
et al. 2014) cats (McEachern et al. 2008), ferrets (Mire 
et al. 2013; Palliser et al. 2013), African green monkeys 
(Prescott et al. 2015) and pigs (Weingartet et al. 2006). 
Little or no clinical signs of disease were observed in 
vaccinated animals after NiV challenge and protection 
against mortality was typically 100% depending on the 
vaccination route and dose (Broder et al. 2016). Another 
group of scientists, Yoneda et al. (2013) proposed a 
recombinant measles virus vaccine expressing NiV 
envelope glycoprotein as an appropriate NiV vaccine 
candidate for use in humans.
 Plant systems have been used to produce recombinant 
proteins as they provide some advantages over other 
expression systems. Plant transient expression can be 
used to produce vaccines at low cost on an agricultural 
scale and with a low risk of contamination of the product 
with animal pathogens as reviewed in (Chen & Lai 2015). 
Furthermore, plant-based vaccines have been proposed 
as a new approach for oral delivery such as expression 
of recombinant protein in edible plants like corn and rice 
(Kapila et al. 1997; Nochi et al. 2007; Shoji et al. 2011). 
Other instances of successful expression of plant-based 
vaccine antigens or virus-like particles include foot and 
mouth disease virus structural protein VP1 expressed 
in transgenic alfalfa plants (Wigdorovitz et al. 1999), 
chimeric peptide containing antigenic determinants from 
rabies virus glycoprotein and nucleoprotein expressed in 
Nicothiana sp. plants (Yusibov et al. 2002), cholera toxin 
B subunit expressed in transgenic tobacco chloroplasts 
(Daniell et al. 2001), recombinant subunit hemagglutinin 
of influenza A virus expressed in Nicothiana benthamiena 
(Kalthoff et al. 2010; Mett et al. 2008; Shoji et al. 2011, 
2008) and extracellular domain of matrix protein 2 (M2e) 
of influenza A virus expressed in Nicothiana benthamiena 
(Mardanova 2015). 
 In the current study, we investigated expression of 
the recombinant NiV G protein in N. benthamiana using 
a non-replicating transient expression vector. The purified 
product showed reactivity with the antibodies present 
in anti-NiV antisera, as demonstrated in Western blot 
analysis. This study provides an important exploration of 
a plant-synthesed recombinant NiV G protein as a vaccine 
candidate. 
MATERIALS AND METHODS
PLANT VIRAL VECTOR AND ANTISERUM
CPMV-based plant viral expression vector, pEAQ-HT was 
a kind gift from Professor George Lomonosoff (John Innes 
Centre, UK). Rabbit anti-NiV serum was obtained from the 
Veterinary Research Laboratory (VRI), Ipoh, Malaysia. 
BACTERIAL STRAINS, PLANT MATERIALS AND 
GROWTH CONDITIONS
E.coli (XL1-Blue, Stratagene) and Agrobacterium 
tumefaciens strain LBA4404 were used in molecular cloning 
experiments and were routinely cultured at 37ºC and 28ºC, 
respectively, in Luria-Bertani (LB) media supplemented 
with appropriate antibiotics: Ampicillin (100 μg/mL), 
kanamycin (50 μg/mL) and rifampicin (50 μg/mL). N. 
benthamiana plants were grown in a greenhouse and 
maintained at 20ºC ± 2, under a 12-h light/dark cycle. 
CONSTRUCTION OF RECOMBINANT VECTOR AND 
TRANSFORMATION OF AGROBACTERIUM
The NiV G gene synthesis (GenBank accession no. 
HM545086.1) was carried out by Genescript USA (www.
genescript.com). A cDNA fragment encoding the NiV G 
gene was synthesized de novo as shown in Figure 1 and 
with the following elements: AgeI and SmaI restriction 
sites were added at the 5’ and 3’ ends, respectively; the 
native signal region of NiVG protein was replaced with a 
the tobacco PR1a signal sequence of pathogenesis-related 
protein (90 bp) GenBank accession no. X06930); the native 
NiV G protein transmembrane domain (148 bp - 210 bp) 
was eliminated; an endoplasmic reticulum (ER) retention 
signal peptide (KDEL) and a cMyc-tag were added the 
C-terminal encoding region to facilitate target protein 
detection. The synthetic recombinant NiV G construct was 
cloned into a Cowpea mosaic virus-based plant expression 
binary vector, pEAQ-HT (Sainsbury et al. 2009a), using 
the AgeI and SmaI (Promega, USA) restriction sites. The 
ligation generated an N-terminal hexahistidine-tag to the 
NiV G protein construct, for affinity purification and a stop 
codon to end the translation. The resulting recombinant 
construct (named as NiV-G/pEAQ) was then transformed 
into XL1-Blue E. coli competent cells by the heat shock 
method. The colonies containing the recombinant plasmid 
were identified and confirmed using colony PCR and by 
DNA sequencing using a commercial service (1st Base, 
Malaysia). PCR was performed in a 25 μL reaction volume 
containing 0.05 U of Taq Polymerase, 2.5 μL buffer (50 
mM KCl, 10 mM Tris-HCl pH8.3, 1.5 mM MgCl2), 100 ng 
template DNA, 200 μM of each dNTP and 25 nM of each 
primer (NiVGF 5’ ACC GGT ATG GGA TTT GTT CTC 3’ 
and NiVGR 5’ CCC GGG CAG ATC TTC TTC AGA 3’). 
PCR was run in a programmable thermocycler (Biometra, 
Germany) with an initial denaturation at 94°C for 4 min 
followed by 20 cycles of denaturation at 94°C for 45 s, 
then annealing at 45°C for 45 s followed by extension at 
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72°C for 1 min followed by a final extension at 72°C for 5 
min. The PCR-amplified product was resolved in 1% (w/v) 
agarose gel by electrophoresis at 80 V and analyzed using 
Gene Flash Syngene Bio Imaging (TopoGEN, USA). One 
microliter of the purified recombinant plasmids was then 
introduced into chemically competent A. tumefaciens, 
LBA 4404 by transformation using a freeze-thaw method 
(Weigel & Glazebrook 2006). 
FIGURE 1. Construction of recombinant vector, NiV-G/pEAQ. (A) Sequence of the de novo synthesised cDNA fragment encoding 
NiV G. Restriction sites (AgeI and SmaI), are underlined; signal sequence (tobacco PR1a) shown in bold; NiV G cDNA with 
removal of native signal sequence and transmembrane domain are shown in normal font; KDEL sequences are shaded with grey 
and cMyc-tag sequences are italicised. (B) Schematic diagram of pEAQ-HT vector and insertion position of 
G gene in between AgeI and SmaI sites (Adapted from Sainsbury et al. 2009a)
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AGROINFILTRATION OF NICOTIANA BENTHAMIANA
A. tumefaciens LBA4404 clones containing either empty 
vector pEAQ-HT or recombinant NiV-G/pEAQ were 
confirmed by colony PCR and thereafter named Ag/pEAQ-
HT and Ag/NiVG-pEAQ, respectively. The cultures were 
grown to stable phase with an optical density (OD600) of 
1.2-1.4 in LB medium supplemented with 50 μg/mL of 
rifampicin and kanamycin at 28°C and shaken at 200 rpm. 
The cells were then collected by micro-centrifugation at 
6,000 rpm for 10 min at 4°C and resuspended in infiltration 
buffer (10 mM 2-N-morpholinoethane sulphonic acid 
(MES), pH5.5, 10 mM MgCl2, 0.1 mM acetosyringone) 
to an OD600 of between 0.3 and 0.4. After 2 h incubation 
at room temperature to induce the virulence gene, the 
suspensions were infiltrated into fully expanded mature 
leaves of 8-week old N. benthamiana plants using a syringe 
without a needle. After infiltration, the plants were grown 
under greenhouse conditions at 20±2ºC, under a 12-h light/
dark cycle. The growth and physical appearance of the 
infiltrated leaves were monitored and recorded.
MRNA ASSESSMENT OF NIVG/PEAQ-INFILTRATED 
PLANT SAMPLES
Leaf samples from both Ag/pEAQ-HT and Ag/NiVG-
pEAQ-infiltrated plants were harvested on 3, 6, 9 and 
12 days post-infiltration (dpi) for total RNA extraction 
using TRIzol reagent (Invitrogen, USA) following the 
manufacturer’s protocol. Reverse transcription (RT) was 
conducted on the RNAs extracted using a Viva 2-step 
RT-PCR kit (Vivantis, Malaysia). The first-strand cDNA 
synthesis reaction mixture was prepared by adding 2 μg of 
total RNA, 2 μM gene-specific primer (NiVGR), 0.5 mM 
dNTP mixture and DEPC-treated water up to a total of 10 μL 
volume. Mixtures were incubated at 65°C for 5 min then 
placed on ice for 2 min. A 10 μL mixture of 1X RT buffer 
(500 mM Tris-HCl (pH 8.3 at 25°C), 750 mM KCl, 30 
mM MgCl2 and 100 mM DTT) and 100 U MMuLV Reverse 
Transcriptase was added to each tube. The mixture was 
incubated at 42°C for 60 min. The reaction was terminated 
at 85°C for 5 min and chilled on ice. PCR reactions were as 
described in the previous section and included a reaction 
with RNA without first strand cDNA synthesis as a negative 
control to track DNA contamination. The PCR products 
were then examined following electrophoresis at 80 V in 
1.0% (w/v) agarose gel. RT-PCR reactions were performed 
in triplicate. ImageJ software was used to quantify the 
absolute band intensity for comparison of expression at 
different dpi. 
PROTEIN EXTRACTION AND SDS-PAGE ELECTROPHORESIS
Proteins were extracted from the Ag/pEAQ-HT and Ag/
NiVG-pEAQ infiltrated leaves at 3, 6, 9 and 12 dpi as 
follows: Inoculated leaf tissues were frozen in liquid 
nitrogen and ground to powder using mortar and pestle. 
Then, the samples were suspended in 2 volumes of soluble 
protein buffer (50 mM Tris-HCl pH 7.25, 150 mM NaCl, 2 
mM DTT and 1/100 protease inhibitor cocktail) and micro-
centrifuged at 13,000 rpm for 10 min at 4°C. Supernatants 
were collected and stored at 4°C. Extracted protein was 
quantified by spectrophotometer (ND-1000, Nanodrop) 
using a Bio-Rad protein assay with bovine serum albumin 
standards. Following this, protein was separated by 
electrophoresis at 120 V for 90 min in 12% SDS-PAGE.
PROTEIN PURIFICATION
A column was prepared using 5 mL of nickel–nitrilotriacetic 
acid (Ni–NTA) agarose (Life Technologies, USA) that 
was suspended thoroughly and pre-equilibrated. The 
supernatant was loaded onto the column. The protein-
bound Ni–NTA resin was first washed with 10 mL of 
denaturing binding buffer (8 M urea; 20 mM NaPO4, pH 
7.8; 500 mM NaCl) followed by washing with 20 mL of 
denaturing wash buffer (8 M urea; 20 mM NaPO4, pH6.0; 
500 mM NaCl). The column was washed with another 
20 mL of the above washing buffer at pH5. The bound 
recombinant protein was eluted with 10 mL denaturing 
elution buffer (8 M urea; 20 mM NaPO4, pH4.0; 500 mM 
NaCl) and the sample fractions were analyzed by 12% 
SDS-PAGE and Western blotting (as described below). The 
fractions containing the purified recombinant protein were 
pooled and dialyzed against 6 M urea for 6 h. The dialysis 
was continued with the addition of 250 mL of 25 mM Tris–
HCl (pH7.5) every 12 h for 36 h, then the dialysis solution 
was replaced with 25 mM Tris–HCl (pH7.5), 150 mM 
NaCl, 0.2% Triton X-100 and 5 mM β-mercaptoethanol 
and dialysed for another 12 h. The concentration of the 
recombinant G protein pooled from the eluted fractions 
containing the purified recombinant protein was quantified 
with Bio-Rad protein assay reagent (Bio-Rad, USA) using 
bovine serum albumin as a standard.
WESTERN BLOTTING ANALYSIS
After protein sample separation on 12% SDS-PAGE gel, 
the gel was either stained with Coomassie Brilliant blue 
or transferred onto nitrocellulose membranes (Invitrogen, 
USA) by electroblotting. Membranes were blocked with 
5% (w/v) non-fat dried milk in 1X PBS buffer (137 mM 
NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4 and 
0.05 % (v/v) Tween-20) to prevent nonspecific binding 
of antibodies and then probed with primary antibody 
for 2 h at room temperature. Then, each membrane was 
washed three times with 1X PBS buffer and incubated with 
secondary antibody for 1.5 h at room temperature. The 
following antibody combinations were used: Murine anti-
cMyc antibody (1/500 dilution) as the primary antibody 
and alkaline phosphatase conjugated rabbit anti-mouse 
IgG (1/5000 dilution) as the secondary antibody; primary 
rabbit polyclonal IgG antibody against NiV (1:10,000 
dilution) generously provided by the Veterinary Research 
Laboratory (VRI), Ipoh, Malaysia and alkaline phosphatase 
conjugated rabbit anti-rabbit IgG as the secondary antibody 
(Zymed, USA) (1: 10,000 dilution). After washing three 
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times in 1X PBS buffer, the membranes blotted with 
G-protein were incubated with 3 mL of 5-Bromo-4-chloro-
3-indolyl phosphate/Nitro blue tetrazolium (BCIP/NBT) 
colour development substrate solution (Sigma-Aldrich) 
until signal was observed. Western blot was performed 
in triplicate. ImageJ software was used to quantify the 
absolute band intensity for comparison of expression at 
different dpi.
RESULTS
CONSTRUCTION AND TRANSFORMATION OF NiV-G/pEAQ
The NiV G gene was inserted successfully into pEAQ-HT 
vector via AgeI and SmaI restriction sites. Following the 
gene cloning, the recombinant vector was characterised 
and identified by PCR and restriction endonuclease 
digestion. The digestion of the vector with AgeI and XhoI 
yielded fragments of approximately 10 kbp and 1.65 kbp 
as expected for pEAQ-HT vector and NiV G fragments, 
respectively, while digestion of the vector with SmaI 
yielded a band of about 12 Kbp, the expected size for 
the linearized NiVG/pEAQ (Figure 2A). The resulting 
recombinant vector was introduced into A. tumefaciens, 
FIGURE 2. Restriction digestion profile and colony PCR of 
recombinant NiVG/pEAQ
(A) Restriction digestion profile of recombinant NiVG/pEAQ. Lane M: Vivantis 1kb 
ladder; Lane 1: NiVG/pEAQ digested with SmaI; Lane 2: NiVG/pEAQ digested 
with AgeI and SmaI. (B) Lanes 1-3: Colony PCR of recombinant NiVG/pEAQ. 
Lane M: Vivntis 1kb ladder
FIGURE 3. Physical appearances of N. benthamiana leaves infiltrated with Ag/NiVG-pEAQ cultures 
Each leaf was infiltrated with OD600 0.3-0.4 of Ag/NiVG-pEAQ cultures. Representitve leaves shown at 0, 3, 6, 9 and 12 dpi.
LBA 4404 by transformation and the recombinant 
transformants were selected using kanamycin (100 μg/mL) 
on LB agar plates and confirmed by colony PCR (Figure 2B).
TRANSIENT EXPRESSION, PURIFICATION AND 
QUANTIFICATION OF RECOMBINANT PROTEIN
When infiltration was conducted with Ag/pEAQ-HT, 
the plant leaves showed the infiltrated zones bleached 
gradually (Figure 3). RT-PCR amplification of RNA samples 
extracted from Ag/NiVG-pEAQ-infiltrated leaves at 3, 
6, 9 and 12 dpi using G-specific primers (NiVGF and 
NiVGR) produced a distinct band of approximately 1.65 
kbp, indicating transcription of G gene sequences in the 
plants (Figure 4). Transcripts were detected 3 days after 
inoculation and reached maximum expression at 9 dpi. 
 After total protein extraction and Western blotting 
analysis, the soluble fraction of protein was specifically 
recognised by anti-cMyc antibody. Bands of approximately 
60 kDa corresponding to the predicted size for the 
recombinant G protein were observed on Western blots 
of the protein fractions from infiltrated leaves at 3, 6, 9 
and 12 dpi (Figure 5). The strongest band was observed 
from the protein fraction of infiltrated leaves at 9 dpi 
which showed the maximum expression of recombinant 
NiV G protein. Moreover, the recombinant NiV G protein 
showed reactivity with rabbit anti-NiV serum. Based on 
the expression results from RT-PCR (Figure 4) and Western 
blotting (Figure 5), infiltrated plants at 9 dpi showed the 
highest expression and so plants at 9 dpi were harvested for 
NiG protein quantification. The recombinant protein was 
purified using Ni-charged IMAC resin and each 1 mL elution 
fraction was collected and analysed by SDS-PAGE (Figure 
6). Purified protein was observed in elution fractions 2 to 
6 and those fractions were pooled, dialysed and the protein 
concentration determined, giving a maximum estimated 
yield of 0.1 mg recombinant NiV G-protein per gram of 
fresh weight of leaves. 
DISCUSSION
Outbreaks of NiV with human fatalities have occurred 
almost annually since 2001 in India and Bangladesh 
(Broder 2012; Clayton et al. 2016; Herriman 2005; Luby et 
al. 2009).  Hence, it is imperative to find effective measures 
to avert future NiV pandemics. Vaccine development has 
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applications, contaminating the human food chain (Fischer 
et al. 2004).
 Various virus-based vectors have been engineered and 
applied successfully for recombinant protein production in 
plant systems, for example tobacco mosaic virus (TMV)-
based (Lindbo 2007; Musiychuk et al. 2007; Roy et al. 
2010). and cowpea mosaic virus (CPMV)-based vectors 
(Sainsbury & Lomonossoff 2008). However, none of 
these vectors is commercially available. In the present 
study, a versatile vector, pEAQ-HT, was chosen because 
this vector allows rapid and simple transient expression 
of multiple protein products from a single plasmid with a 
great reduction of plasmid backbone size; the P19 coding 
gene sequences incorporated into the T-DNA region and 
single step insertion of target gene sequence which eases 
preparation. This vector system also lacks the concerns 
of bio-containment as no infectious virus particles 
are produced (Sainsbury et al. 2009a; Sainsbury & 
Lomonossoff 2008). The vector pEAQ-HT is based on an 
adapted version of CPMV RNA2, with a hyper translatable 
5’-leader sequence and modified 3’-unstranslated region 
(UTR) within pBINPLUS binary vector (Sainsbury & 
Lomonossoff 2008). This vector has been very useful for 
heterologous protein expression in N. benthamiana leaves 
Sainsbury et al. 2009b) and in suspension cell cultures 
(Sun et al. 2011).
 In order to express NiV G protein in a plant-based 
expression system, we constructed a plant virus-based 
vector, NiV-G/pEAQ and expressed this transiently 
in N. benthamiana as a step towards potential vaccine 
development for protection against this human and animal 
pathogen. Several criteria were considered for high level 
expression of functional NiV G protein in N. benthamiana: 
the replacement of the native viral signal peptide of 
NiV G protein with PR1-a signal peptide, removal of 
the N-terminal transmembrane domain, and the addition 
of endoplasmic reticulum (ER) retention signal. The 
replacement of the native NiV G protein signal peptide 
with a cleavable apoplast targeting signal from tobacco 
pathogenesis related protein PR1-a and the removal of 
transmembrane domain, were to promote the target gene 
expression in N. benthamiana. This was demonstrated by 
Agarwal et al. (2000), where 1.5-fold higher expression 
was observed for human α-1-antitrypsin protein expressed 
using a PR1-a targeting signal as compared to other signal 
peptides used. This signal peptide has been regularly used 
for heterologous expression in N. benthamiana together 
with ER retention signal KDEL (Kanagarajan et al. 2013; 
Eshaghi et al 2005). As with other heterologous protein 
expression application, one crucial concern for vaccine 
production is protein solubility. In the case of NiV G 
protein, the presence of the transmembrane domain, the 
membrane anchor sequence on NiV G gene is known to 
interfere with solubility of the recombinant NiV G protein, 
so it is common practice in NiV G protein expression to 
remove it (Bossartet al. 2005; Eshaghi et al 2005; Liu et al. 
2007). Hence, in the present study, to increase solubility, 
the transmembrane domain was removed.
FIGURE 4. RT-PCR amplification of RNA extracted from N. 
benthamiana leaves infiltrated with Ag/NiVG-pEAQ
(a) Upper panel: Lane M: FermentasGeneRuler™ 1 kb ladder; lane 1: cDNA of N. 
benthamiana leaves infiltrated with Ag/pEAQ-HT harvested at 9 dpi as a negative 
control; lanes 2-5: cDNA of Ag/NiVG-pEAQ-infiltrated leaves harvested at 3, 6, 
9 and 12 dpi, respectively. Lower panel: ethidium bromide-stained agarose gel 
showing 28S and 18SrRNA of the RNA samples used in RT-PCR. (b) Mean band 
intensity value of RT-PCR shown in (A).
(a)
(b)
become crucial to combat this disease. Some vaccines for 
NiV have been developed and some of the products are 
now in clinical trials, such as single-dose live-attenuated 
vesicular stomatitis virus-based vaccine (DeBuysscher et 
al. 2016; Prescott et al. 2015), a subunit vaccine, consisting 
of a recombinant soluble and oligomeric form of the G 
glycoprotein of Hendra virus (Bossart et al. 2005; Mason 
et al. 1992; Satterfield et al. 2016). 
 In this study, a plant-based expression system was 
chosen as such systems have been shown to have promise 
for vaccine development, for example Hepatitis B virus 
vaccine which is the first plant-based vaccine produced 
by tobacco in 1992 (Mason et al. 1992), Influenza virus 
vaccine (Petukhova et al. 2013), and Ebola virus vaccine 
(Qiu et al. 2014), both produced in N. benthamiana. Plant 
systems are favoured as they are considered safe, low-cost, 
rapid to upscale and less vulnerable to contamination with 
human or animal pathogens compared with traditional 
inactivated vaccines and animal or microbial cell 
culture–based vaccines (reviewed in Rybicki 2014). N. 
benthamiana was chosen for this study because of its status 
as a well-established expression host, its high biomass 
yields and its rapid scalability. This species is popular 
as a non-food, non-feed crop that reduces the risk of 
non-food transgenic proteins, such as those for medicinal 
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 The addition of an endoplasmic reticulum retention 
signal (KDEL) in the C-terminal region can increase the 
protein quality and stability as it leads to the retention of 
the target protein in the ER and prevents the entry of the 
protein into the Golgi apparatus (Schouten et al. 1996). 
The prevention of entry of a heterologous protein into the 
Golgi apparatus can reduce plant-specific glycosylation 
and improve recombinant protein quality (Petruccelli 
et al. 2006). The ER contains a relatively low amount 
of proteolytic enzymes and the presence of molecular 
chaperones favours disulphide bond formation and correct 
protein folding, together with an oxidizing environment 
(Faye et al. 2005; Nuttall et al. 2002) which can improve 
heterologous protein stability. The positive impacts of ER 
retention have been documented for various recombinant 
proteins production, including antibodies (Stoger et al. 
2002), human interleukin-4 (Gomord et al. 2004; Ma et al. 
2005),  SARS corona virus S protein antigen (Pogrebnyak 
et al. 2005), Aspergillus phytase (Peng et al. 2006) and 
synthetic silk-like protein DR1B (Yang et al. 2005).
 In this study, cMyc-tag sequences were fused to the 
C-terminal encoding region of the G protein cDNA to 
facilitate target protein detection, while a His-tag sequence 
was fused to the C-terminal end of G protein cDNA to 
facilitate the purification of recombinant proteins by 
Ni-NTA resin. The detection of an approximately 60 kDa 
protein from Ag/NiVG-pEAQ infiltrated leaves, but not 
in Ag/pEAQ-HT-infiltrated leaves showed that the plant-
FIGURE 5. Western blot of G protein isolated from N. benthamiana leaves
(a) Lane M: molecular weight marker (MagicMark™ XP Western Protein Standard); Lane 1: Leaves infiltrated with Ag/pEAQ-HT (negative 
control) harvested at 9 dpi and probed with anti-cMyc antibody; Lanes 2-5: Leaves infiltrated with Ag/NiVG-pEAQ at 3, 6, 9, and 12 dpi 
respectively, probed with anti-cMyc antibody; Lane 6, Nickel column-purified G protein extracted at 9 dpi and probed with anti-NiV antibody. 




based Nipah virus G protein had been produced in N. 
benthamiana and could be expressed using a CPMV-based 
vector system. These results agree with the studies reported 
by Eshaghi et al. (2005) and Liu et al. (2007) and our 
own report (Gan et al. 2015) showing that NiV G protein 
expression at approximate 60 kDa in Escherichia coli.
 RT-PCR and Western blotting analyses confirmed 
the transcription and translation of NiV G protein in 
infiltrated leaves (Figures 4, 5 and 6) with maximum 
levels of transcription and translation of NiV G protein 
in N. benthamiana at 9 dpi and an estimated yield of 0.1 
mg recombinant NiV G-protein per gram of fresh weight 
of leaves. This expression profile is similar to those in 
other reports where maximum expression of heterologous 
proteins in plants was reached between 3 and 9 dpi (Pua 
et al. 2012; Sheludko et al. 2007; Wroblewski et al. 2005; 
Wydro et al. 2006).  Kanagarajan et al. (2013) reported 
the highest relative expression of both amorpha-4,11-
diene synthase and epi-cegrol synthase gene at 9 dpi in 
N. benthamiana. Wroblewski et al. (2005) have shown 
that the intensity of GUS staining in Arabidopsis reached 
the peak level within 4 to 5 dpi and decreased gradually 
after 5 dpi. GFP accumulation achieved maximum level 
at 3 dpi and remained stable up to 8 dpi in tobacco 
(Sheludko 2007) while Mardanova et al. (2015) observed 
the maximal expression of matrix protein 2 of Influenza 
A virus recombinant protein at 4 dpi in N. benthamiana. 
In several reports, the production of recombinant proteins 
in plants gradually decreased at around 9 dpi, possibly 
caused by RNA silencing which reduces heterologous 
gene expression or may induce systemic necrosis in N. 
benthamiana (Johansen & Carrington 2011; Scholthof et 
al. 1993; Voinnet et al. 2003; Zhang et al. 2010). However, 
the necrosis symptom was not observed in our study.
 A specific signal was observed in Western blots 
probed with anti-NiV antibody confirming the specific 
immunoreactivity of the recombinant NiV G protein 
(Figure 5). This was in contrast to our previous study of 
Niv G protein expression in E. coli (Gan et al. 2015), where 
the 60 kDa protein reacted with anti-cMyc antibodies in 
Western blots but not with anti-Niv antibody, showing the 
plant-expressed NiV G protein to have a more specific 
reaction with the antibody. Based on our results, we suggest 
that an N. benthamiana transient expression system using 
a viral vector can be employed for large-scale production 
of recombinant proteins to for functional studies to 
elucidate their potential for various industrial and medical 
applications. 
CONCLUSION
In summary, a modified vector containing NiV G protein 
sequence was constructed and has been expressed in 
N. benthamiana. The recombinant NiV G protein had 
reactivity to NiV antibodies, indicating its potential for 
vaccine use. 
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